Capital Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Capital Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-594	Closed	-$296K	–	40
2025 Q1	$296K	Hold	594	–	–	0.12%	36
2024 Q4	$309K	Hold	594	–	–	0.13%	37
2024 Q3	$367K	Sell	594 -80	-12%	-$47.4K	0.16%	33
2024 Q2	$373K	Hold	674	–	–	0.17%	35
2024 Q1	$392K	Sell	674 -3	-0.4%	-$1.68K	0.19%	34
2023 Q4	$359K	Buy	677 +3	+0.4%	+$1.45K	0.18%	38
2023 Q3	$341K	Hold	674	–	–	0.19%	37
2023 Q2	$352K	Hold	674	–	–	0.19%	36
2023 Q1	$388K	Buy	+674	New	+$380K	0.22%	35
2019 Q4	–	Sell	-709	Closed	-$206K	–	35
2019 Q3	$206K	Hold	709	–	–	0.22%	31
2019 Q2	$208K	Buy	+709	New	+$195K	0.21%	34

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital Wealth Management's TMO Position: Q2 2025 in Review

Capital Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 594 shares — an estimated $296K sold.

Capital Wealth Management first reported a position in TMO in Q2 2019 and held it in 11 quarters. The position peaked at $392K in Q1 2024. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Capital Wealth Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Capital Wealth Management sold 594 Thermo Fisher Scientific shares in Q2 2025, an estimated $296K.
Capital Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 11 quarters.
Capital Wealth Management's Thermo Fisher Scientific position peaked at $392K in Q1 2024.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Capital Wealth Management's 13F filing for Q2 2025, filed 9 Jul 2025.